Table 6 Adverse reactions after 5-Fu-DEB-TACE and 5-Fu-cTACE treatments.

From: 5-Fluorouracil combined with CalliSphere drug-eluting beads or conventional transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score weighting analysis

Adverse event

5-Fu-DEB-TACE

5-Fu-cTACE

p-Value

I

II

III

IV

I

II

III

IV

Nausea

13(19.6%)

1(1.5%)

0

0

14(21.5%)

0

0

0

0.964

Vomiting

10(15.1%)

2(3.0%)

0

0

11(16.9%)

0

0

0

0.850

Fever

7(10.6%)

6(9.1%)

0

0

10(15.3%)

1(1.5%)

0

0

0.682

Abdominal pain

38(57.5%)

10(15.1%)

0

0

23(35.3%)

8(12.3%)

0

0

0.003

Hepatotoxicity

25(37.8%)

19(28.7%)

0

0

32(49.2%)

22(33.8%)

0

0

0.031

Liver abscess

0

0

1

0

0

0

0

0

-

  1. DEB-TACE, drug-eluting beads trans-arterial chemoembolization; cTACE, conventional trans-arterial chemoembolization; 5-Fu, 5-Fluorouracil.
Back to article page